CPT code 87507 represents a multiplex nucleic acid amplification test that detects 12–25 gastrointestinal pathogens or subtypes, including common bacterial, viral, and parasitic agents. This molecular diagnostic panel is clinically important for rapid, comprehensive identification of infectious causes of acute gastroenteritis, which can guide infection control, public health reporting, and targeted patient management. Nationally, adoption of multiplex molecular panels has grown as laboratories and clinicians seek faster, more sensitive diagnostics compared with traditional culture or single-target assays.

Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. The publication outlines payer coverage patterns, coding and billing considerations, and clinical context relevant to laboratory and hospital billing teams. Readers will find benchmarks for utilization and reimbursement where available, summaries of relevant policy trends, and practical context for interpreting the clinical role of this panel in acute gastrointestinal illness evaluation. Data not available in the input will be noted as such. The content is intended to inform billing, compliance, and laboratory operations stakeholders about the service profile and payer landscape for CPT code 87507 at a national level.